Erfurt-Rhoda, Germany

Jörg Stürzebecher


Average Co-Inventor Count = 2.6

ph-index = 5

Forward Citations = 58(Granted Patents)


Company Filing History:


Years Active: 1996-2012

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Jörg Stürzebecher: Innovator in Blood Coagulation and Urokinase Inhibition

Introduction

Jörg Stürzebecher is a notable inventor based in Erfurt-Rhoda, Germany. He has made significant contributions to the fields of blood coagulation and cancer treatment through his innovative patents. With a total of five patents to his name, Stürzebecher's work has the potential to impact medical practices significantly.

Latest Patents

One of Stürzebecher's latest patents focuses on the anticoagulation of human blood ex vivo. This invention describes a method that maintains blood calcium concentration, prevents thrombin formation, and preserves thrombocyte function. Additionally, it introduces a blood coagulation factor Xa inhibitor that can be effectively utilized in this method. The anticoagulated blood produced can be used for examining cellular blood components, particularly for diagnosing thrombocyte function.

Another significant patent involves new urokinase inhibitors featuring a triisopropylphenylsulfonyl residue as an Nα-substituent for 3-amidinophenylalanine. The introduction of this residue enhances the compounds' affinity to urokinase, thereby increasing their inhibitory activity. These urokinase inhibitors are valuable for understanding the role of urokinase and its receptor in various diseases, especially in tumor propagation and metastasis. The patent also includes methods for treating tumors and a pharmaceutical composition.

Career Highlights

Throughout his career, Jörg Stürzebecher has worked with various companies, including Wilex AG. His innovative approaches and research have positioned him as a key figure in his field, contributing to advancements in medical treatments.

Collaborations

Stürzebecher has collaborated with notable professionals such as Luis Moroder and Stefan Sperl. These partnerships have likely enriched his research and development efforts, leading to impactful innovations.

Conclusion

Jörg Stürzebecher's contributions to the fields of blood coagulation and cancer treatment through his patents demonstrate his commitment to advancing medical science. His innovative methods and collaborations highlight the importance of research in developing effective treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…